mTHPC-loaded extracellular vesicles outperform liposomal and free mTHPC formulations by an increased stability, drug delivery efficiency and cytotoxic effect in tridimensional model of tumors
暂无分享,去创建一个
Ilya Yakavets | Marie Millard | Lina Bezdetnaya | Max Piffoux | Florence Gazeau | Claire Wilhelm | Henri-Pierre Lassalle | C. Wilhelm | F. Gazeau | J. Guigner | J. Jasniewski | L. Bezdetnaya | I. Yakavets | Jordane Jasniewski | M. Piffoux | Jean-Michel Guigner | Amanda Brun | Henri-Pierre Lassalle | Marie Millard | Amanda Brun | H. Lassalle | A. Brun
[1] A. Fahr,et al. Liposomes in topical photodynamic therapy , 2012, Expert opinion on drug delivery.
[2] H. S. de Bruijn,et al. Fluorescence localization and kinetics of mTHPC and liposomal formulations of mTHPC in the window‐chamber tumor model , 2011, Lasers in surgery and medicine.
[3] R. Schiffelers,et al. Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[4] E. Korn,et al. Interaction of phospholipid vesicles with cells. Endocytosis and fusion as alternate mechanisms for the uptake of lipid-soluble and water-soluble molecules , 1975, The Journal of cell biology.
[5] Melani A Solomon,et al. Development of an in vitro tumor spheroid culture model amenable to high-throughput testing of potential anticancer nanotherapeutics , 2016, Journal of liposome research.
[6] Arjen Amelink,et al. Ex vivo quantification of mTHPC concentration in tissue: influence of chemical extraction on the optical properties. , 2008, Journal of photochemistry and photobiology. B, Biology.
[7] H. Maeda,et al. A Retrospective 30 Years After Discovery of the Enhanced Permeability and Retention Effect of Solid Tumors: Next‐Generation Chemotherapeutics and Photodynamic Therapy—Problems, Solutions, and Prospects , 2016, Microcirculation.
[8] T. Knobloch,et al. Comparison of intracellular accumulation and cytotoxicity of free mTHPC and mTHPC-loaded PLGA nanoparticles in human colon carcinoma cells , 2011, Nanotechnology.
[9] F. Berr,et al. Comparative characterization of the efficiency and cellular pharmacokinetics of Foscan®- and Foslip®-based photodynamic treatment in human biliary tract cancer cell lines , 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[10] D. Vernon,et al. Identification and Partial Characterization of an Unusual Distribution of the Photosensitizer meta‐Tetrahydroxyphenyl Chlorin (Temoporfin) in Human Plasma , 1999, Photochemistry and photobiology.
[11] Ji-Ho Park,et al. Liposome-based engineering of cells to package hydrophobic compounds in membrane vesicles for tumor penetration. , 2015, Nano letters.
[12] F. Guillemin,et al. Correlation between in vivo pharmacokinetics, intratumoral distribution and photodynamic efficiency of liposomal mTHPC. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[13] F. Guillemin,et al. Interaction of Liposomal Formulations of Meta‐tetra(hydroxyphenyl)chlorin (Temoporfin) with Serum Proteins: Protein Binding and Liposome Destruction , 2012, Photochemistry and photobiology.
[14] Molly M Stevens,et al. Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[15] C. Maake,et al. Photoinduced effects of m-tetrahydroxyphenylchlorin loaded lipid nanoemulsions on multicellular tumor spheroids , 2016, Journal of Nanobiotechnology.
[16] E. Reddi,et al. Uptake and photo-toxicity of Foscan®, Foslip® and Fospeg® in multicellular tumor spheroids. , 2016, Journal of photochemistry and photobiology. B, Biology.
[17] Max J H Witjes,et al. Photochemical internalization (PCI)‐mediated enhancement of bleomycin cytotoxicity by liposomal mTHPC formulations in human head and neck cancer cells , 2014, Lasers in surgery and medicine.
[18] François Guillemin,et al. Necrotic and apoptotic features of cell death in response to Foscan photosensitization of HT29 monolayer and multicell spheroids. , 2005, Biochemical pharmacology.
[19] Hongxu Lu,et al. Multicellular Tumor Spheroids (MCTS) as a 3D In Vitro Evaluation Tool of Nanoparticles. , 2018, Small.
[20] R. Bonnett,et al. Photobleaching of compounds of the 5,10,15,20-Tetrakis(m-hydroxyphenyl)porphyrin Series (m-THPP, m-THPC, and m-THPBC). , 2002, Organic letters.
[21] R. Gurny,et al. State of the art in the delivery of photosensitizers for photodynamic therapy. , 2002, Journal of photochemistry and photobiology. B, Biology.
[22] M G Nichols,et al. Fluence rate effects in photodynamic therapy of multicell tumor spheroids. , 1993, Cancer research.
[23] T. Dougherty. An update on photodynamic therapy applications. , 2002, Journal of clinical laser medicine & surgery.
[24] V. Pandey,et al. Ethosomes: versatile vesicular carriers for efficient transdermal delivery of therapeutic agents , 2015, Drug delivery.
[25] T. Pellegrino,et al. Cell-derived vesicles as a bioplatform for the encapsulation of theranostic nanomaterials. , 2013, Nanoscale.
[26] Pieter Vader,et al. Extracellular vesicles for drug delivery. , 2016, Advanced drug delivery reviews.
[27] L. Bezdetnaya,et al. Drug delivery to solid tumors: the predictive value of the multicellular tumor spheroid model for nanomedicine screening , 2017, International journal of nanomedicine.
[28] F. Guillemin,et al. Redistribution of meta-tetra(hydroxyphenyl)chlorin (m-THPC) from conventional and PEGylated liposomes to biological substrates , 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[29] M. Senge,et al. Temoporfin (Foscan®, 5,10,15,20‐Tetra(m‐hydroxyphenyl)chlorin)—A Second‐generation Photosensitizer †,‡ , 2011, Photochemistry and photobiology.
[30] G. Scherphof,et al. Transfer and exchange of phospholipid between small unilamellar liposomes and rat plasma high density lipoproteins. Dependence on cholesterol content and phospholipid composition. , 1981, Biochimica et biophysica acta.
[31] M. Bureau,et al. Magnetic and photoresponsive theranosomes: translating cell-released vesicles into smart nanovectors for cancer therapy. , 2013, ACS nano.
[32] François Guillemin,et al. Investigation of Foscan interactions with plasma proteins. , 2005, Biochimica et biophysica acta.
[33] Pieter Vader,et al. Extracellular vesicles as drug delivery systems: lessons from the liposome field. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[34] Han-Soo Kim,et al. Engineering of extracellular vesicles as drug delivery vehicles. , 2017, Stem cell investigation.
[35] L. Battistini,et al. Acridine Orange/exosomes increase the delivery and the effectiveness of Acridine Orange in human melanoma cells: A new prototype for theranostics of tumors , 2017, Journal of enzyme inhibition and medicinal chemistry.
[36] David Kessel,et al. Photodynamic therapy of cancer: An update , 2011, CA: a cancer journal for clinicians.
[37] S. May,et al. Transfer mechanism of temoporfin between liposomal membranes. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[38] G. Zheng,et al. Liposomal nanostructures for photosensitizer delivery , 2011, Lasers in surgery and medicine.
[39] A. Urbani,et al. A Perspective on Extracellular Vesicles Proteomics , 2017, Front. Chem..
[40] F. Guillemin,et al. Assessment of Apoptosis by Immunohistochemistry to Active Caspase-3, Active Caspase-7, or Cleaved PARP in Monolayer Cells and Spheroid and Subcutaneous Xenografts of Human Carcinoma , 2009, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[41] Gaurav Sahay,et al. The exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agents. , 2010, Biomaterials.
[42] José Villalaín,et al. Influence of liposome charge and composition on their interaction with human blood serum proteins , 1993, Molecular and Cellular Biochemistry.
[43] Alissa M. Weaver,et al. Extracellular Vesicles: Unique Intercellular Delivery Vehicles. , 2017, Trends in cell biology.
[44] Abraham H. Abouzeid,et al. Cancer cell spheroids for screening of chemotherapeutics and drug-delivery systems. , 2015, Therapeutic delivery.
[45] F. Guillemin,et al. Characterization of Photodegradation of Meta‐tetra (Hydroxyphenyl)chlorin (mTHPC) in Solution: Biological Consequences in Human Tumor Cells , 1998, Photochemistry and photobiology.
[46] P. Morlière,et al. Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan® localisation in cultured tumour cells , 2003, British Journal of Cancer.
[47] F. Bonte,et al. Interactions of liposomes with serum proteins. , 1986, Chemistry and physics of lipids.